Tenaya Therapeutics, Inc. (TNYA) › Shareholders' EquityTenaya Therapeutics, Inc. (TNYA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$43.74M2020: -$81.31M2021: $278.53M2022: $243.38M2023: $139.42M2024: $92.85M2025: $123.27M$123.27M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$123.27M+32.8%2024$92.85M-33.4%2023$139.42M-42.7%2022$243.38M-12.6%2021$278.53M+442.5%2020-$81.31M-85.9%2019-$43.74M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share